MEDVi vs Ro: Which GLP-1 Provider Is Better?
Short answer: Ro scores higher on our rubric, 7.2/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.
Ro beats MEDVi overall, scoring 7.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Ro is $149/mo membership + medication. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program. Choose Ro for users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing.
A side-by-side look at MEDVi and Ro to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
MEDVi
#46 of 54MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.
Visit MEDViRo
#38 of 54One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.
Visit Ro| Feature | MEDVi | Ro |
|---|---|---|
| Why each one | Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication. | The most trusted name in telehealth with the fastest prescription turnaround, same-day approval is standard, not the exception. |
| Our Score | 5.7/10 | 7.2/10 |
| Headline Price | $179 first month, then $299/mo | $149/mo membership + medication |
| Medication Type | Both | Brand |
| Insurance Accepted | No | Yes |
| Best For | Users who want both oral and injectable compounded options in one telehealth program | Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing |
| Watch out for | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication | Membership and medication are billed separately, readers need to add them together for the all-in monthly cost |
| Ranking | #46 | #38 |
| Get started | Visit MEDVi | Visit Ro |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
- −The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Ro
Pros
- +Carries Foundayo (orforglipron), Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026, at $149-$349 depending on dose and refill timing via LillyDirect matching
- +Direct insurance billing with major carriers, with coverage, Wegovy or Zepbound can cost $0-25/mo copay
- +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
- +Claims matched pricing with LillyDirect, NovoCare, and TrumpRx, some of the lowest cash brand prices available
Cons
- −Membership and medication are billed separately, readers need to add them together for the all-in monthly cost
- −Brand-name only, no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
- −Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)
Our Verdict
Ro edges out MEDVi with a score of 7.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Ro is $149/mo membership + medication. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. MEDVi offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving MEDVi and Ro.
- MEDVi vs PeterMDfrom $165/mo
- MEDVi vs Yucca Healthfrom $146/mo
- MEDVi vs Wellorithmfrom $147/mo
- Ro vs Fridays$249/mo month-to-month
- Ro vs Henry Medsfrom $199/mo
- Ro vs Hone Healthfrom $309/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Ro · 7.2/10